MMP9 and subarachnoid hemorrhage: In an experimental model of subarachnoid hemorrhage (SAH) in mice, intravenously injected COG133 resulted in improved BBB function by inhibiting the CypA-NF-κB-MMP9 pathway and reduced neuronal pyroptosis by actively suppressing NLRP3 inflammasome cascade activation [151,154].